Packages (Simulation)
Reagent Preparation
Image (I)
Certificate
Mini Samples ELISA Kit for Myeloid Progenitor Inhibitory Factor 2 (MPIF2)
CCL24; SCYA24; Ckb-6; Eotaxin-2; Chemokine C-C-Motif Ligand 24; Eosinophil chemotactic protein 2; Small Inducible Cytokine Subfamily A(Cys-Cys)Member 24
- Product No.MEA695Mu
- Organism SpeciesMus musculus (Mouse) Same name, Different species.
- Sample Typen/a
- Test MethodDouble-antibody Sandwich
- Assay Length3h
- Detection Rangen/a
- Sensitivityn/a
- Downloadn/a
- UOM 48T96T 96T*5 96T*10 96T*100
- FOB
US$ 424
For more details, please contact local distributors! US$ 605 US$ 2723 US$ 5143 US$ 42350
Specificity
This assay has high sensitivity and excellent specificity for detection of Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2).
No significant cross-reactivity or interference between Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) and analogues was observed.
Recovery
Matrices listed below were spiked with certain level of recombinant Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) and the recovery rates were calculated by comparing the measured value to the expected amount of Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) in samples.
Matrix | Recovery range (%) | Average(%) |
serum(n=5) | 90-102 | 99 |
EDTA plasma(n=5) | 96-104 | 101 |
heparin plasma(n=5) | 90-103 | 95 |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Mini Samples Myeloid Progenitor Inhibitory Factor 2 (MPIF2) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
Sample | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 79-101% | 95-103% | 87-97% | 85-97% |
EDTA plasma(n=5) | 87-98% | 92-104% | 81-94% | 82-95% |
heparin plasma(n=5) | 99-105% | 85-99% | 83-97% | 81-103% |
Stability
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Reagents and materials provided
Reagents | Quantity | Reagents | Quantity |
Pre-coated, ready to use 96-well strip plate | 1 | Plate sealer for 96 wells | 4 |
Standard | 2 | Standard Diluent | 1×20mL |
Detection Reagent A | 1×120µL | Assay Diluent A | 1×12mL |
Detection Reagent B | 1×120µL | Assay Diluent B | 1×12mL |
TMB Substrate | 1×9mL | Stop Solution | 1×6mL |
Wash Buffer (30 × concentrate) | 1×20mL | Instruction manual | 1 |
Assay procedure summary
1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.